Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2021-08-03 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
公告董事會通過110年第二季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1720 生達) reporting the board's approval of the consolidated financial report for the second quarter of the year 110 (Taiwan calendar, equivalent to 2021). It includes cumulative financial data for the period 110/1/1 to 110/6/30, such as revenue, gross profit, operating profit, net profit before tax, net profit, net profit attributable to parent company owners, earnings per share, total assets, total liabilities, and equity attributable to parent company owners. The document is short (881 characters) and appears to be a formal announcement of the board's approval of the interim financial report rather than the full report itself. It does not contain detailed financial statements or substantive analysis but summarizes key financial figures. Therefore, it fits best as an Interim / Quarterly Report (IR) since it reports comprehensive financial data for a period shorter than a full fiscal year (half-year). H1 2021
2021-08-03 Chinese
公告本公司董事會決議變更110年股東常會召開日期 (依金管會公告「因應疫情公開發行公司股東會延期召開 相關措施」辦理)
AGM Information Classification · 95% confidence The document is a short announcement (653 characters) from a company (1720 生達) regarding a board resolution to change the date of the Annual General Meeting (AGM) for the year 110 (Taiwan calendar year). It specifies the new AGM date, time, and location, and references compliance with regulatory measures due to the pandemic. There is no detailed financial data, no full report, and it is clearly an announcement about the scheduling of the AGM. According to the classification rules, such announcements about AGM scheduling fall under AGM Information (AGM-R). The document is not a full report, nor a voting result, nor a proxy statement. Therefore, the correct classification is AGM Information (AGM-R) with high confidence.
2021-07-13 Chinese
公告本公司董事會決議現金股利配息基準日
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from the company's general manager regarding the board resolution on the cash dividend distribution date, including details such as dividend amount, ex-dividend date, record date, and payment date. It does not contain financial statements or detailed financial analysis but is an official notice about dividend payment details. The document length is only 694 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2021-07-13 Chinese
110年06月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, supervisors, and executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which is characteristic of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement or a brief summary but a detailed disclosure of insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-07-09 Chinese
110年06月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 生達化學製藥股份有限公司. It lists share counts held by directors, supervisors, and executives, including pledged shares and shares held by spouses or minors. The document is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. It is not a report or announcement of financial results, nor a regulatory filing about board changes or voting results. The content matches the definition of a Director's Dealing report, which involves reporting personal share transactions or holdings by company directors and executives. The document length is 2455 characters, which is consistent with a detailed insider shareholding disclosure rather than a full financial report or announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-07-09 Chinese
110年6月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, presented in a tabular format with explanations about accounting standards and reporting practices. It contains actual financial data for a specific month (June 2021) and compares it to the previous year. The document length is short (774 characters) but it includes substantive financial data, not just an announcement or a link to a report. It is not a full annual or interim report but rather a periodic financial summary. Given the presence of monthly and cumulative revenue data and the nature of the content, this fits best as an Interim / Quarterly Report (IR). H1 2021
2021-07-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.